eClinical Tools for Better Clinical Trials
Medrio (medrio.com) scores 80 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, SaaS brands, Technology brands, in the 70th percentile of 6168 Healthcare brands.
Medrio is an eClinical technology company that provides electronic data capture (EDC) and related clinical trial software, including EDC/CDMS, ePRO/eCOA, eConsent, and RTSM tools. It targets clinical research organizations, sponsors, and small-to-mid-sized clinical teams running trials from early phase through post-market. Medrio positions its platform as a validated, audit-ready, all-in-one alternative to complex enterprise systems, drawing on over 20 years of use across thousands of clinical trials.
| Brand Name | Medrio |
|---|---|
| Domain | medrio.com |
| Industry | Healthcare, SaaS |
| Main Competitors | Castor EDC (84/100), Medidata (89/100), Veeva Vault EDC (88/100), Oracle Clinical One (81/100), Viedoc, OpenClinica, Signant Health (80/100) |
Moz Domain Authority 36/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #286,960 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Discover our leading eClinical tools for faster, more accurate clinical trial research. Request your demo today." (Meta description: 16 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt mentions GPTBot, ChatGPT-User, ClaudeBot, Google-Extended, PerplexityBot - all allowed - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost, HubSpot.
Social footprint: verified profiles on X (Twitter), Instagram, YouTube, GitHub; no detected presence on LinkedIn, Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Medrio?", Claude could identify the brand as of September 2026. Medrio is a clinical trial software company that provides electronic data capture (EDC) and clinical data management tools, aimed particularly at small to mid-sized biotech, medical device, and pharmaceutical companies running clinical trials. Best known for Cloud-based EDC software designed for fast setup and use in clinical trials, especially popular with smaller and mid-sized research organizations.
When asked "Best brands similar to Medrio?", Claude would recommend Medrio as of September 2026. It's a well-regarded name in clinical trial data management software, often mentioned alongside other EDC providers for companies seeking simpler, faster-to-deploy alternatives to larger enterprise systems.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Medrio's main competitors in Healthcare: Castor EDC (84/100), Medidata (89/100), Veeva Vault EDC (88/100), Oracle Clinical One (81/100), Signant Health (80/100).
Sources: Brand Analyzer scan
Medrio offers an eClinical technology platform that includes Electronic Data Capture (EDC) and Clinical Data Management System (CDMS) tools, electronic Patient-Reported Outcomes and Clinical Outcome Assessments (ePRO/eCOA), electronic informed consent (eConsent), and Randomization and Trial Supply Management (RTSM). These tools are combined into an all-in-one platform for managing clinical trial data and operations.
Sources: Medrio official site
Medrio has limited AI-search visibility, scoring 35/100 on Brand Analyzer's AI visibility composite (visibility 18, trust 51, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Medrio official site
Medrio scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Medrio official site
Medrio is an eClinical technology company that provides software tools for clinical trial research, including electronic data capture (EDC), electronic patient-reported outcomes (ePRO/eCOA), eConsent, and randomization and trial supply management (RTSM). It is designed for clinical research organizations, sponsors, and small-to-mid-sized clinical teams conducting trials from early phase through post-market.
Sources: Medrio official site
Medrio develops and delivers eClinical software used to manage and streamline clinical trial data collection and operations. Its platform includes EDC/CDMS for data capture and management, ePRO/eCOA for patient-reported outcomes, eConsent for electronic informed consent, and RTSM for randomization and trial supply management. The goal is to help research teams run trials more efficiently and accurately.
Sources: Medrio official site
Medrio can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Medrio official site
Medrio is used by clinical research organizations, sponsors, and small-to-mid-sized clinical teams that conduct trials ranging from early phase through post-market. Its platform is designed to serve teams that need validated clinical trial technology without the complexity of larger enterprise systems.
Sources: Medrio official site
Medrio is known for offering a validated, audit-ready EDC platform built specifically for small and scaling clinical research teams, positioning itself between overly complex enterprise systems and lightweight tools with limited capability. It emphasizes over 20 years of clinical use across thousands of trials as evidence of reliability.
Sources: Medrio official site
Medrio scores 35/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Medrio has a weak AI-visibility profile at 35/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (51/100) and its weakest is visibility (18/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #286,960 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and a low Moz Domain Authority of 36/100. In a live check, Claude could already identify Medrio from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Medrio: MediSked (80/100), Medisafe (80/100), Mehiläinen (80/100), Merck Millipore (80/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), ZOLL Data Systems (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.